Astrana Health (NASDAQ:ASTH) Upgraded to Hold at Macquarie

Macquarie upgraded shares of Astrana Health (NASDAQ:ASTH) to a hold rating in a research note released on Monday morning,Zacks.com reports.

Other equities research analysts have also recently issued research reports about the company. TD Cowen started coverage on Astrana Health in a research note on Monday, October 14th. They issued a “buy” rating and a $66.00 price objective for the company. Robert W. Baird upped their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a report on Wednesday, November 13th. KeyCorp began coverage on shares of Astrana Health in a research report on Friday, October 11th. They set a “sector weight” rating for the company. Finally, BTIG Research lifted their price target on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Astrana Health currently has an average rating of “Moderate Buy” and an average price target of $65.17.

Astrana Health Trading Down 1.4 %

Shares of ASTH stock opened at $35.04 on Monday. The company has a market cap of $1.97 billion, a P/E ratio of 26.95, a PEG ratio of 1.80 and a beta of 1.13. Astrana Health has a fifty-two week low of $34.11 and a fifty-two week high of $63.20. The stock has a 50 day simple moving average of $48.57 and a two-hundred day simple moving average of $48.08. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts’ consensus estimates of $0.33. The business had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same period last year, the company posted $0.47 earnings per share. Research analysts forecast that Astrana Health will post 1.16 earnings per share for the current year.

Hedge Funds Weigh In On Astrana Health

Institutional investors have recently added to or reduced their stakes in the business. GAMMA Investing LLC purchased a new stake in Astrana Health in the third quarter valued at approximately $34,000. Nisa Investment Advisors LLC bought a new stake in Astrana Health during the third quarter worth about $35,000. KBC Group NV purchased a new position in shares of Astrana Health in the 3rd quarter worth about $70,000. Quarry LP bought a new stake in Astrana Health in the 3rd quarter worth approximately $77,000. Finally, Quest Partners LLC bought a new position in Astrana Health during the third quarter valued at approximately $133,000. 52.77% of the stock is currently owned by institutional investors.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.